A Rare Case of Levetiracetam-Induced Refractory Hypokalemia

Levetiracetam is a Food and Drug Administration (FDA)-approved drug for partial, generalized, and myoclonic seizures. Its mechanism of action as an antiepileptic involves the release of neurotransmitters from synaptic vesicles. The common side effects of levetiracetam include sleepiness, weakness, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Coughlin, Paige, Patel, Goonja, Vadaketh, Jessica, Pandit, Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067888/
https://www.ncbi.nlm.nih.gov/pubmed/35530900
http://dx.doi.org/10.7759/cureus.23817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067888/
https://www.ncbi.nlm.nih.gov/pubmed/35530900
http://dx.doi.org/10.7759/cureus.23817

Ejemplares similares